0001562180-20-004611.txt : 20200619
0001562180-20-004611.hdr.sgml : 20200619
20200619161003
ACCESSION NUMBER: 0001562180-20-004611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200618
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRANCIS LAURA
CENTRAL INDEX KEY: 0001218802
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38701
FILM NUMBER: 20975729
MAIL ADDRESS:
STREET 1: C/O SI-BONE, INC.
STREET 2: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SI-BONE, Inc.
CENTRAL INDEX KEY: 0001459839
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 262216351
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
BUSINESS PHONE: 4082070700
MAIL ADDRESS:
STREET 1: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
FORMER COMPANY:
FORMER CONFORMED NAME: SI-Bone Inc.
DATE OF NAME CHANGE: 20090326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-06-18
false
0001459839
SI-BONE, Inc.
SIBN
0001218802
FRANCIS LAURA
C/O SI-BONE, INC.
471 EL CAMINO REAL, SUITE 101
SANTA CLARA
CA
95050
false
true
false
false
Chief Financial Officer
Common Stock
2020-06-18
4
M
false
2418.00
4.68
A
141639.00
D
Common Stock
2020-06-18
4
M
false
5158.00
4.32
A
146797.00
D
Common Stock
2020-06-18
4
S
false
5158.00
17.0673
D
141639.00
D
Common Stock
2020-06-18
4
S
false
2418.00
17.0673
D
139221.00
D
Common Stock
2020-06-19
4
M
false
2395.00
4.32
A
141616.00
D
Common Stock
2020-06-19
4
S
false
2395.00
17.3008
D
139221.00
D
Stock Option (Right to Buy)
4.68
2020-06-18
4
M
false
2418.00
0.00
D
2027-03-01
Common Stock
2418.00
13695.00
D
Stock Option (Right to Buy)
4.32
2020-06-18
4
M
false
5158.00
0.00
D
2025-05-25
Common Stock
5158.00
150945.00
D
Stock Option (Right to Buy)
4.32
2020-06-19
4
M
false
2395.00
0.00
D
2025-05-25
Common Stock
2395.00
148550.00
D
The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $17.28, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.06 to $17.41, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
Includes 86,134 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
/s/ Michael A. Pisetsky, Attorney-in-Fact for Laura A. Francis
2020-06-19